Pancreatic Amylase

CPT: 82150
Print Share


  • Amylase Fractionation
  • Isoamylase

Expected Turnaround Time

2 - 4 days

Related Information

Related Documents

Specimen Requirements


Serum (preferred); lithium heparin plasma is acceptable.


2 mL

Minimum Volume

1 mL


Red-top tube, gel-barrier tube, or green-top (heparin) tube


Separate serum or plasma from cells within 30 minutes of collection.

Storage Instructions

Room temperature; stable for seven days. Stable refrigerated for one month.

Causes for Rejection

Hemolysis; use of anticoagulants other than lithium heparin (Citrate and fluoride inhibit the assay reaction.)

Test Details


Evaluate pancreatic disease. Amylase is primarily produced in the pancreas and salivary glands. Isoenzymes may be used to determine the source of an elevated amylase concentration. Measurement of pancreatic amylase activity is of value in diagnosing pancreatitis and other pancreatic disorders which result in elevation of serum and urine amylase.


Patients with macroamylase may have elevated pancreatic amylase results. The elevation is due to the higher than normal level of pancreatic amylase in the macroimmune complex. This elevated pancreatic amylase is not diagnostic for pancreatitis, however, measurement of an elevated pancreatic amylase in urine is confirmatory of pancreatitis, pancreatic trauma, or pancreatic carcinoma since macroamylases are too large for renal clearance (see Additional Information).


Salivary amylase is inhibited by specific antibodies and the remaining pancreatic amylase is determined by an enzymatic, colorimetric method.

Reference Interval

See table.


Male (units/L)

Female (units/L)

0-1 years

Not established

Not established

2-17 years



18-60 years



>60 years



Additional Information

Macroamylases are sometimes present in sera. These rare forms are probably complexes between ordinary amylase (usually S-type) and IgA, IgG, or other high molecular weight plasma proteins. These macroamylases cannot be filtered through the glomeruli of the kidney because of their large size (MW >200,000) and are thus retained in the plasma where their presence may increase amylase activity to some six- to eightfold over that observed in health. In macroamylasemia, amylase activity in the urine is lower than normal, since less amylase is cleared by the kidneys. No clinical symptoms are associated with this disorder; however, many of these cases have been detected following investigation of abdominal pain.


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
123111 Pancreatic Amylase, S 1805-1 123111 Pancreatic Amylase, S U/L 1805-1

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at